SKIN AQUA, the No. 1 selling sunscreen for three consecutive years *,
is renewing its Super Moisture Gel and Essence on Wednesday, February 1st!
The renewed formula combines environmental friendliness with superior sun protection!
January 27, 2023
ROHTO Pharmaceutical Co., Ltd., Ltd. (Headquarters: Osaka City, President: Masafumi Sugimoto, hereinafter referred to as Rohto Pharmaceutical) will be renewing its popular "Super Moisture Gel" and "Super Moisture Essence" from its "SKIN AQUA" line, which has been the No. 1 selling product in terms of units sold for three consecutive years *. While maintaining the water-like feel, the products are now equipped with "Light-Resistant Capsule NEO ★". The formula uses environmentally friendly materials while achieving high sun protection.
We support the healthy skin of each and every customer under the sun, and continue our approach to making society a better place, aiming for a world of well-being. Our products will be relaunched nationwide at drugstores, variety stores, and e-commerce sites starting February 1st, 2023 (Wednesday).
*: Intage SRI+ Sunscreen (Gel) Market, by Major Series, Sales Volume, June 2019 - May 2022
SKIN AQUA Super Moisture Gel c, SKIN AQUA Super Moisture Essence c
Number 1 in sales volume * That's why we're evolving with an eye on the future.
SKIN AQUA was created in 2008 with the aim of providing a sunscreen that is easy to use every day to protect healthy and beautiful skin. It can be used generously on the face and the whole body, and we have received many positive comments such as "It spreads easily like water" and "My skin feels more moisturized after applying it."
As the No. 1 selling sunscreen gel in the market for three consecutive years *, SKIN AQUA will continue to evolve to offer comfortable and sustainable UV protection solutions for both our customers and society, looking towards the future.
*Percentage of respondents who answered "very satisfied," "satisfied," or "somewhat satisfied" regarding their satisfaction with SKIN AQUA Super Moisture Gel b (old formula). n=103, July 2020, Rohto survey.
Featuring a completely revamped core technology, it incorporates the "Light-Resistant Capsule NEO ★," which took three years to develop.
Background
In 2014, we developed "Watery Capsules," a core technology that supports high sun protection and a comfortable feel. To deliver even better value in a sustainable way, we have revamped our core technology. After three years of development, we have realized and incorporated "Light-Resistant Capsule NEO ★," which also takes environmental considerations into account.
Light-resistant capsule NEO ★ points
The capsule's base material is silica, a naturally derived ingredient that is considerate of both people and the environment. Furthermore, we selected a UV absorber that blocks a wide range of ultraviolet rays, from UVA to UVB, and is less prone to degradation of its UV-blocking function due to light exposure.
At the same time, by using a technology that encapsulates more of these ingredients in capsules, we have achieved both high sun protection and environmental friendliness, transforming it into a new core technology.
Renewal points: Achieving three elements, including a comfortable user experience.
By incorporating "Light-Resistant Capsule NEO ★" and our accumulated expertise in sunscreen research, we are renewing the formula to provide an even more comfortable user experience.
-
Blocks a wide range of ultraviolet rays, from UVA to UVB.
Thanks to "Light-Resistant Capsule NEO ★," it blocks a wide range of ultraviolet rays while also containing ingredients that prevent the UV-cutting function from degrading due to ultraviolet light and other forms of light.
-
Commitment to environmental considerations
By using capsules made from the natural mineral silica, we have achieved environmental consideration.
-
A pleasant feeling that moisturizes with every use.
Formulated with three moisturizing ingredients. Sodium hyaluronate and ultra-low molecular weight hyaluronic acid retain moisture on the skin's surface and deep within the stratum corneum, while skin-adsorbing hyaluronic acid locks in moisture on the skin's surface. It has a watery texture that makes it easy to use every day.
*: Ultra-low molecular weight hyaluronic acid (hydrolyzed sodium hyaluronate), skin-adsorbing hyaluronic acid (hydroxypropyltrimonium hyaluronate)
★: Bis-ethylhexyloxyphenol methoxyphenyl triazine (UV-blocking ingredient), silica
In its second year on the market, "SKIN AQUA Nexta" is launching a new product: "Tone-Up Serum UV Essence".
Nexta UV Essence T
From our "SKIN AQUA Nexta" sunscreen series, designed with environmental considerations in mind and tailored for mature skin, we are launching a new tone-up * serum pack UV. It keeps your skin moisturized all day long **, leading to radiant, healthy-looking skin *.
-
Tone-up function to address dullness in adult skin *
Rose color x gold pearl ☆ Contains a glossing agent to correct dullness and create a radiant, beautiful complexion that doesn't look chalky.
-
Non-chemical (UV absorber-free) formula designed for mature skin.
For skin that has become more sensitive to stress as we age, we have adopted a non-chemical formula.
While incorporating a high concentration of UV scattering agents to provide excellent UV protection, this product offers a smooth feel that minimizes dryness and tightness.
☆: Mica, Titanium Oxide
*: Due to makeup effect
**: From application in the morning until removal in the evening
The history of Rohto Pharmaceutical's sunscreen formulation technology
Sunscreen is essential for protecting healthy and beautiful skin. Rohto Pharmaceutical has conducted extensive research over many years to ensure that customers can use sunscreen positively, as if it were part of their daily skincare routine.
- "NEVER SAY NEVER" is a registered trademark of ROHTO Pharmaceutical Co., Ltd., Ltd.
- "SKIN AQUA" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
- "NEXTA" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
- "Beauty Serum Pack UV/NEXTA" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.